UBS O'Connor’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-366,664
Closed -$3.62M – 972
2022
Q1
$3.62M Buy
366,664
+6,462
+2% +$63.6K 0.04% 392
2021
Q4
$3.54M Buy
360,202
+9,647
+3% +$94.2K 0.03% 376
2021
Q3
$3.41M Buy
350,555
+100,391
+40% +$972K 0.03% 402
2021
Q2
$2.43M Buy
+250,164
New +$2.45M 0.02% 446

Other funds holding BTMD

UBS O'Connor's BTMD Position: Q2 2022 in Review

UBS O'Connor sold out of Biote Corp (BTMD) in Q2 2022, closing a stake of 366,664 shares — an estimated $3.62M sold.

UBS O'Connor first reported a position in BTMD in Q2 2021 and held it in 4 quarters. The position peaked at $3.62M in Q1 2022. 12 funds tracked by Wall St. Rank hold BTMD as of Q2 2022.

  • UBS O'Connor reported no remaining Biote Corp position as of Q2 2022 after selling out during the quarter.
  • UBS O'Connor sold 366,664 Biote Corp shares in Q2 2022, an estimated $3.62M.
  • UBS O'Connor first reported a position in Biote Corp in Q2 2021 and held it in 4 quarters.
  • UBS O'Connor's Biote Corp position peaked at $3.62M in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Biote Corp as of Q2 2022.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.